(Reuters) -Shares in Evotec soared 22% on Monday after private equity firm Triton confirmed a close to 10% stake in the German drug development company, and a media report said it was weighing a ...
Triton Partners is considering a takeover bid for Germany’s Evotec SE, according to people familiar with the matter, after the private equity firm emerged as one of the drug developer’s largest ...
Evotec SE (NASDAQ:EVO) ADRs surged 20% in premarket trading after a report that Triton Partners is considering a takeover offer for the German drug developer. The investment firm has been trying to ...
The sophomore point guard jumped in with 26 points, four assists and four steals in the team's opener vs. Columbus East. The ...
A Disney Cruise ship headed for Bermuda rescued four stranded boaters off a sinking catamaran Sunday morning. The 50-foot ...
European shares maintained gains on Monday as the post-US election rally continued, while Evotec shares surged on a report that private equity outfit Triton was mulling a bid for the German drug ...